European Investment Bank and EC provided CureVac with $75 million financing for vaccine development and expansion of manufacturing
On Jul. 6, 2020, the European Investment Bank (EIB) and CureVac announced they had entered into a $75…
Sinovac COVID-19 vaccine collaboration with Butantan received approval from Brazilian regulator for phase III trial
On Jul. 6, 2020, Sinovac Biotech announced that on Jul. 3, 2020, the Brazilian National Regulatory Agency, Anvisa,…
Immune Regulation partnered with DynPort Vaccine to advance drug product for COVID-19 into clinical trials
On Jul. 9, 2020, Altimmune announced that it had entered into a teaming agreement with DynPort Vaccine Company…
Emergent BioSolutions signed five-year agreement for large-scale drug substance manufacturing for Johnson & Johnsonï¾’s COVID-19 vaccine candidate
On Jul. 6, 2020, Emergent BioSolutions announced a five-year manufacturing services agreement with Janssen Pharmaceuticals, a Johnson &…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Therapeutics | Vaccine
UConn-made COVID-19 custom mask solution to be manufactured
On Jul. 2, 2020, UConn announced a licensing deal with Connecticut Biotech, a startup company headquartered in South…
Intravacc in-licensed CimCure’s iBoost technology, expanding its vaccine platform portfolio
On Jul. 1, 2020, Intravacc announced the signing of a strategic partnership agreement with Dutch based CimCure, focusing…
NIH ACTIV vaccine working group weighed role of human challenge studies for SARS-CoV-2 vaccine development
On Jul. 1, 2020, in a Perspective for the New England Journal of Medicine, members of the NIHï¾’s…
Pfizer and BioNTech announced early positive data from ongoing phase 1/2 study of mRNA-based vaccine candidate against SARS-CoV-2
On Jul. 1, 2020, Pfizer and BioNTech announced preliminary data from the most advanced of four investigational vaccine…
Altimmune announces dosing of first patient in phase 1b clinical trial of NasoShieldï¾™ single dose intranasal anthrax vaccine candidate
On Jun. 30, 2020, Altimmune announced dosing of the first patient in the Companyï¾’s Phase 1b clinical trial…
Bharat Biotech COVID-19 vaccine – COVAXIN received DCGI approval for phase I & II Human clinical trials
On Jun. 29, 2020, Bharat Biotech announced it had successfully developed COVAXIN, India’s 1st vaccine candidate for COVID-19,…
COVID-19 Therapeutics Accelerator donors launched international alliance to connect research data sources and enable collaboration
On Jun. 26, 2020, the COVID-19 Therapeutics Accelerator donors and partners announced the formation of the International COVID-19…
Vaxart signed Memorandum of Understanding with Attwill Medical Solutions Sterilflow
On Jun. 26, 2020, Vaxart announced that its oral COVID-19 vaccine had been selected to participate in a…
Entos announced selection of lead candidates for pan-Coronavirus Fusogenix DNA vaccine and $42 million award
On Jun. 25, 2020, Entos Pharmaceuticals announced the selection of two lead candidates for a pan-coronavirus Fusogenix DNA…
University of British Columbia received $14 million in federal funding for COVID-19 research
On Jun. 25, 2020, researchers at the University of British Columbia announced they had received a combined total…
Vaxart signed Memorandum of Understanding with Attwill Medical Solutions Sterilflow
On Jun. 25, 2020, Vaxart announced it had signed a Memorandum of Understanding with Attwill Medical Solutions Sterilflow,…
Moderna and Catalent announced collaboration for fill-finish manufacturing of Moderna’s COVID-19 vaccine candidate
On Jun. 25, 2020 Moderna announced a collaboration for large-scale, commercial fill-finish manufacturing of Moderna’s mRNA-based COVID-19 vaccine…
LabCorp launched new neutralizing antibody test
On Jun. 25, 2020, LabCorpï¾® announced the launch of a new test that can be used to assess…
Symbiosis and AstraZeneca signed supply agreement for sterile manufacture of COVID-19 vaccine for clinical trials
On Jun. 24, 2020, Symbiosis Pharmaceutical Services, an India-based specialist provider of pharmaceutical and vaccine development services, announced…
Sinovac received approval from China for its quadrivalent influenza vaccine
On Jun. 24, 2020, Sinovac Biotech announced the China National Medical Products Administration (NMPA) issued a product license…
Mateon selected by IBM Watson Health for use of IBM Clinical Development Solution to support clinical COVID-19 vaccine candidates
On Jun. 24, 2020, Oncotelic, a wholly owned subsidiary of Mateon Therapeutics, announced that IBM has granted access…
Texas A&M researchers testing COVID-19 vaccine candidates for iBio
On Jun. 24, 2020, a team of scientists at Texas A&M University announced it is working with iBio…
Universal mosquito vaccine tested
On Jun. 23, 2020, the NIH announced it had tested a ﾓuniversal mosquito vaccineï¾” known as AGS-v. It…
Sanofi and Translate Bio expanded collaboration and license agreement to develop mRNA vaccines for infectious diseases
On Jun. 23, 2020, Sanofi and Translate Bio announced they had agreed to expand their existing 2018 collaboration…
INOVIO received $71 million contract from U.S. Dept of Defense to scale up manufacture of CELLECTRA 3PSP smart device
On Jun. 23, 2020, INOVIO announced it had received $71 million funding from the U.S. Department of Defense…
Intranasal immunization with Intravaccï¾’s experimental whooping cough vaccine confered broad protection
On Jun. 22, 2020, Intravacc announced promising results of a preclinical study with its experimental whooping cough vaccine…
Pfizer announced start of four phase 3 clinical trials for investigational vaccines
On Jun. 22, 2020, Pfizer announced the initiation of four phase 3 clinical trials within its current pipeline…
GSK COVID-19 vaccine development collaboration with Clover Biopharmaceuticals began clinical trials
On Jun. 19, 2020, GSK announced that a scientific collaboration with Clover Pharmaceuticals to develop an adjuvanted COVID-19…
Dynavax announced first participants dosed in phase 1 clinical trial evaluating Clover Biopharma’s COVID-19 S-Trimer vaccine candidate with CpG 1018 adjuvant
On Jun. 19, 2020, Dynavax Technologies announced the first participants were dosed in the Phase 1 clinical trial…
Tonix Pharma and Southern Research announced expansion of COVID-19 vaccine collaboration
On Jun. 18, 2020, Tonix Pharmaceuticals announced an expansion of its strategic collaboration with Southern Research to include…
Oxford University and Bvlgari announced collaboration to fight COVID-19 and future pandemics
On Jun. 17, 2020, Bvlgari, the Italian luxury brand, announced plans to support research into COVID-19 and vaccine…